On the afternoon of October 24, 2025, during the 24th Annual Academic Conference of the Chinese Medical Association's Andrology Branch, a delegation of medical leaders and experts from across the country visited the WBL production base for an on-site inspection. The visit aimed to comprehensively understand the company's achievements in male health medical technology research and development, product innovation, and production management, while fostering consensus on promoting industry collaboration and high-quality development.

Focusing on Core Technologies and Discussing Innovative Breakthroughs

The delegation first toured the WBL corporate exhibition hall, where they were introduced to the company’s independently developed Low-Intensity Pulsed Ultrasound (LIPUS) therapy devices. This technology uses non-invasive energy focusing to precisely target affected tissues and has been widely applied in the clinical treatment of erectile dysfunction (ED), chronic pelvic pain syndrome (CPPS), and other male health conditions.

Among them, the LIPUS product designed for chronic pelvic pain syndrome (CPPS) became the focal point of attention. This device optimizes algorithms based on years of clinical data, with customized energy parameters and an intelligent temperature control system that significantly improves the efficiency of pelvic floor muscle repair, providing patients with a more comfortable and long-lasting treatment experience. Its non-invasive, safe, and effective characteristics, supported by numerous domestic and international clinical research findings, received high recognition from the visiting experts.

During the visit, the delegation also watched a special feature on WBL’s achievements broadcasted on CCTV12's Sci-Tech China. The program provided a comprehensive overview of the technology, from its principles and clinical applications to its industrial transformation, showcasing how LIPUS technology breaks traditional treatment limitations and offers better solutions for male health patients. This further affirmed the company’s leadership position in technological innovation.

Visiting the Production Line and Ensuring Quality Control

In the production workshop, the delegation observed the entire manufacturing process of the LIPUS series products. From high-precision core component processing to intelligent assembly and debugging, the company strictly follows the ISO 13485 medical device quality management system and implements refined control of the production process through a fully digital traceability system. The production manager explained that each device undergoes multiple quality checks, including performance testing, safety verification, and clinical simulation, ensuring product stability and reliability to provide a solid foundation for clinical applications.

Deepening Collaboration and Discussing Industry Development

At the end of the visit, medical leaders fully acknowledged WBL’s technological expertise and industrial transformation achievements in the male health care field. They also engaged in in-depth discussions on industry development trends. Experts noted that, with the growing demand for male health care diagnostics and treatment, non-invasive and precise technologies such as LIPUS would become a crucial clinical direction. This visit has provided an important opportunity for future technical sharing, multi-center clinical research collaboration, and the formulation of industry standards, which could promote the development of male health care in a more standardized and innovative direction.

Innovation Leading the Way: A New Chapter in Men's Health Care

This visit by medical leaders to WBL’s production base not only recognized the company’s technological strength and production standards but also provided a practical platform for industry collaboration and innovation. The launch of the LIPUS.COM international website marks a new phase in the global dissemination of China’s innovative male health care technology. WBL will continue to uphold its core philosophy of "Innovation Drives Healthcare, Quality Protects Health," deepening the integration of technological research and clinical applications, and working with industry partners to jointly promote the high-quality development of China’s male health care industry.